Skip to content
OpenCapital
Get started

Organogenesis Holdings Inc. ORGO R&D

R&D at other companies

IAR
Integra LifeSciencesIART
$23.5M-5.0%
MiMedx Group logo
MiMedx GroupMDXG
$4.14M+24.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$15.32M-22.5%
Bioventus logo
BioventusBVS
$2.47M-18.1%
Axogen logo
AxogenAXGN
$7.52M+23.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$4.06M-0.9%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×—
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%—
Net margin0.5%+0.3pp
FCF margin6.9%—

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s R&D?
Organogenesis Holdings Inc. (ORGO) reported R&D of $15.16M in Q1 2026.
How has Organogenesis Holdings Inc.'s R&D changed year-over-year?
Organogenesis Holdings Inc.'s R&D increased by 42.5% year-over-year, from $10.64M to $15.16M.
What is the long-term trend for Organogenesis Holdings Inc.'s R&D?
Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s R&D has grown at a 9.7% compound annual growth rate (CAGR), from $30.74M to $44.54M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.